- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
INSECTICID
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Insecticides (India) Limited · Basic Materials · Agricultural Inputs
Latest close
647.7 INR
1.0%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -0.8% below the Trend Line and sits at 24.1% of its 52-week range. The latest completed week returned 1.0%, after a -1.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 54/100.
Setup score
28
out of 100
Latest Close
647.7 INR
7 Aug 2026
1W Return
1.0%
latest completed week
4W Return
-1.7%
short-term follow-through
12W Return
-10.4%
quarterly tape
Trend Breadth
23.1%
12 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.0%
Latest completed week; four-week move -1.7%.
Indicator stack
13/0
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.47%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
54/100
20 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -0.8% below the Trend Line and sits at 24.1% of its 52-week range. The latest completed week returned 1.0%, after a -1.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4412-week average 0.57
12-week confirmation
Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.44Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -1.7% over four weeks, -10.4% over 12 weeks, and -33.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year12
Trend breadth23.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.55Latest activity-pressure read.
Pressure change-4878.1%Four-week change in activity pressure.
Leadership-5.41Latest relative-leadership reading.
RS change10.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 94%
Model confidence 88%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength81/100Blend of value, momentum, and quality. Underlying universe rank 20; rank 1 is best.
Value91/100Relative valuation strength. Underlying universe rank 10; rank 1 is best.
Quality66/100Profitability and accounting quality. Underlying universe rank 35; rank 1 is best.
Momentum9/100Medium-term price momentum. Underlying universe rank 92; rank 1 is best.
Growth24/100Revenue and earnings growth. Underlying universe rank 77; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework87/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 13.5x Price divided by trailing earnings.
- Price / sales
- 0.9x Market value relative to trailing revenue.
- EV / EBITDA
- 8.2x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 0.3% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 31.5% Gross profit retained from each unit of revenue.
- Operating margin
- 9.0% Operating profit retained from revenue.
- Free-cash-flow margin
- 0.3% Free cash flow generated from revenue.
- Return on invested capital
- 11.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 7.1% Latest one-year revenue growth.
- EPS growth
- -1.8% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -89.9% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.3% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.3% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.3x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment54/100
Weighted news tone is neutral across 20 relevant articles.
5 positive · 14 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-38.6%Distance below the 52-week high.
13-week volatility2.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+12.1%Week of 17 Apr.
Worst week-5.9%Week of 13 Mar.
Latest week+1.0%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains10
Flat weeks0
Modest losses8
Sharp losses4
Recent vol2.9%13-week weekly-return volatility.
Base vol4.0%52-week weekly-return volatility.
Up/down split19/33Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank- / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Agricultural Inputs
4-week rank25 / 47
Group average0.9%
Trend breadth19.1%
Trend19.1%active weekly trend signals
MD36.2%positive activity pressure
RS14.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape25/100
Trend, activity pressure, participation, and risk combine to a 25/100 tape read.
Indicator analysis50/100Latest 12-week confirmation: trend 7/12, activity pressure 7/12, relative leadership 4/12.
Activity pressure 0.44; No reversal markers Next-Week ExpectancyNegative 44.47%Next-week expectancy is negative with a 44.47% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors63/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 39; Small Cap Core rank 17 SVQF87/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 205.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment54/100Weighted news tone is neutral across 20 relevant articles.
Insecticides India to discuss Q1 FY27 results on August 11 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 647.7 INR | 1.0% | 653.0 INR | 683.0 INR | -0.55 | -5.41 | 107.1K | Off |
| 31 Jul 2026 | 641.2 INR | 4.1% | 653.4 INR | 681.8 INR | -0.50 | -6.51 | 113.4K | Off |
| 24 Jul 2026 | 616.1 INR | -5.7% | 655.6 INR | 680.7 INR | -0.40 | -8.82 | 122.5K | Off |
| 17 Jul 2026 | 653.4 INR | -0.8% | 658.7 INR | 679.5 INR | -0.22 | -6.57 | 87.5K | On |
| 10 Jul 2026 | 659.0 INR | -0.8% | 660.2 INR | 678.1 INR | -0.01 | -6.04 | 93.4K | On |
| 3 Jul 2026 | 664.1 INR | 0.8% | 661.5 INR | 676.5 INR | 0.19 | -6.24 | 15.7K | On |
| 26 Jun 2026 | 658.6 INR | -4.3% | 663.2 INR | 675.1 INR | 0.36 | -6.84 | 0 | On |
| 19 Jun 2026 | 688.5 INR | -4.2% | 665.3 INR | 673.7 INR | 0.61 | -3.07 | 18.9K | On |
| 12 Jun 2026 | 719.0 INR | 0.6% | 666.4 INR | 672.1 INR | 0.85 | 2.40 | 12.6K | On |
| 5 Jun 2026 | 714.6 INR | -2.8% | 664.6 INR | 670.3 INR | 1.03 | 2.57 | 13.5K | On |
| 29 May 2026 | 735.5 INR | -1.8% | 663.6 INR | 668.6 INR | 1.17 | 4.58 | 135.0K | Off |
| 22 May 2026 | 749.0 INR | 3.6% | 663.1 INR | 666.7 INR | 1.19 | 5.51 | 186.7K | Off |
| 15 May 2026 | 722.8 INR | 0.4% | 662.0 INR | 664.7 INR | 1.15 | 2.21 | 183.9K | Off |
| 8 May 2026 | 720.2 INR | 2.7% | 662.5 INR | 663.0 INR | 1.29 | -0.36 | 111.8K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.